Skip to NavigationSkip to content

News

AstraZeneca's hyperkalaemia drug has been hit with a second rejection by the FDA in the course of a year due to manufacturing issues in the...
NICE has approved Biogen Zinbryta for patients suffering from relapsing remitting multiple sclerosis, though with the caveat of there being...
NICE has released its decision on the fast-track approval process and other changes that will be brought through at the same time – high up on the...
Chinese firm Lumis Global Pharmaceuticals became the latest to face the FDA’s ire as it was hit by a warning over its active pharmaceutical...
Everett, a city north of Seattle in Washington, with a population of 108,000, has accused of Purdue Pharma of failing to adequately prevent the...
Trump’s presidency could cost the industry more than twice as much in regulatory review fees next year, as his administration doubles the proposed...
A study emerging from Denmark has found that the use of over-the-counter pain killer, Ibuprofen, is associated with an increased risk of cardiac...
A new study has emerged looking into life expectancy of those with cystic fibrosis, funded by the US Cystic Fibrosis Foundation, and carried out by...
NICE has released draft guidance provisionally turning down BMS’s Opdivo (nivolumab) for the treatment of classical Hodgkin lymphoma (cHL) in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches